About Alverix
Alverix is a Healthcare company based in San Jose (United States) founded in 2007, and was acquired by Becton Dickinson in January 2014. Portable point-of-care diagnostic instruments and connectivity platforms are developed. Alverix has raised $7.7 million across 1 funding round from investors including BD, Safeguard Scientifics and New Venture Partners. Its focus areas include Life Sciences, Infectious Diseases, In Vitro Diagnostic Tests and Diversified. Its competitors include Inflammatix, Visby Medical and GenMark Diagnostics; 3 of its 3 listed competitors have raised funding.
Company details
Alverix produces instruments and connectivity platforms for diagnostic Point-of-Care (POC) testing. Alverix claims that its systems enable laboratory class quantitative and qualitative assays in a mobile, portable, less expensive format and that this enables extended precision testing beyond high volume sites to physician office labs, retail clinics, emerging markets and the home. Alverix partners with diagnostic and OEM manufacturers who seek to increase current test accuracy, improve the portability of existing tests, or develop new assays for use in physician offices, laboratory outreach locations, retail clinics, and patient homes.Their San Jose Headquarters handles RD, Design Quality Control. Another facility in Penang, Malaysia facility fulfills manufacturing related functions.
- Headquarters San Jose, United States
- Stage Acquired
- SectorsHealthcare
- Website alverix.com
- Social LinkedIn
- Acquired by Becton Dickinson (Jan 2014)
- Total Equity Funding$7.7M (USD)
in 1 rounds
- Latest Funding Round$7.7M (USD), Series A
Feb 2008
- InvestorsBD
& 2 more
- Acquired byBecton Dickinson
(Jan 2014)
Funding Insights of Alverix
Alverix has successfully raised a total of $7.7M through 1 strategic funding round. The most recent funding activity was a Series A round of $7.7 million completed in February 2008. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $7.7M
- Total Rounds 1
- Last Round Series A — $7.7M
- First Round $7.7M
(Feb 2008)
- Investors Count 2
All 1 funding rounds of Alverix with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2008 | $7.7M | Series A | – | New Venture Partners, Safeguard Scientifics | – |
3 investors in total: 3 institutional.
Investors in Alverix
Alverix has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include BD, Safeguard Scientifics and New Venture Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Seed-to-growth investments are made in US and Europe. | nvpllc.com | New Providence, United States | ||
Venture capital firm investing in early and growth stage companies | 1953 | safeguard.com | Radnor, United States | |
BD is recognized for providing innovative medical technology solutions. | 1897 | bd.com | Franklin Lakes, United States |
Investor details for Alverix
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Alverix
3 dated milestones of Alverix across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Alverix is founded.
- Funding First funding round of $7.7M.
- Exit Acquired by Becton Dickinson.
Competitors of Alverix
Alverix has 3 listed competitors in our database, 3 of them funded. They include Inflammatix, Visby Medical and GenMark Diagnostics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| inflammatix.com | 2016 | San Francisco, United States | $191.47M | 54 | Provider of diagnostic solutions for systemic infections | |
| visbymedical.com | 2010 | San Jose, United States | $386.33M | 251 | Portable PCR diagnostics for infectious diseases are developed. | |
| genmarkdx.com | 1993 | San Diego, United States | $8.56M | 797 | Instruments and test panels for multiplexed molecular diagnostics are provided. |
Detailed competitors of Alverix
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Infectious Diseases
3 companies that operate in the same segment as Alverix (Infectious Diseases) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 | |
Therapeutics for drug-resistant bacterial infections are developed. | 2013 | Cambridge, Massachusetts, United States | USD 114.7 M | USD 59.62 M | 32 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Alverix
Alverix was founded in 2007 and raised its 1st funding round 1 year after it was founded.
Alverix is headquartered in San Jose, United States. It is registered at San Jose, California, United States.
Alverix is a funded company, having raised a total of $7.7M across 1 funding round to date. The company's 1st funding round was a Series A of $7.7M, raised on Feb 2008.
Alverix produces instruments and connectivity platforms for diagnostic Point-of-Care (POC) testing. Alverix claims that its systems enable laboratory class quantitative and qualitative assays in a mobile, portable, less expensive format and that this enables extended precision testing beyond high volume sites to physician office labs, retail clinics, emerging markets and the home. Alverix partners with diagnostic and OEM manufacturers who seek to increase current test accuracy, improve the portability of existing tests, or develop new assays for use in physician offices, laboratory outreach locations, retail clinics, and patient homes.Their San Jose Headquarters handles RD, Design Quality Control. Another facility in Penang, Malaysia facility fulfills manufacturing related functions.
Alverix's top competitors include Visby Medical, Inflammatix and GenMark Diagnostics.
Alverix has 3 investors. Key investors include BD, Safeguard Scientifics, and New Venture Partners.
Yes. Alverix was acquired by Becton Dickinson in January 2014.